Physiopathology of prolactin secretion in obesity
- PMID: 10997622
- DOI: 10.1038/sj.ijo.0801291
Physiopathology of prolactin secretion in obesity
Abstract
In many species prolactin is of biological importance and has a major role in determining the deposition and mobilization of fat. In human physiology, outside pregnancy, prolactin secretion is altered by increasing body weight in both children and adults. Prolactin in this circumstance appears to be marker of hypothalamic-pituitary function: the prolactin response to insulin-hypoglycaemia, thyrotrophin releasing hormone stimulation and other stimulatory factors may be diminished. In addition, obesity alters the 24h spontaneous release of prolactin with a generalised dampening of release. A number of explanations have been given as possible causes for these alterations, but it seems likely that they reflect obesity per se and are associated with hyperinsulinaemia. Weight reduction, with accompanying decrease in plasma insulin levels, leads to a normalization of prolactin responses in most, but not all, circumstances. To date, no molecular basis has been identified which links prolactin with increasing body fatness, weight and appetite: new data suggests a possible link in obese men between fasting plasma prolactin and leptin concentrations.
Similar articles
-
Impaired hypothalamic control of prolactin secretion in massive obesity.Lancet. 1979 Apr 7;1(8119):747-50. doi: 10.1016/s0140-6736(79)91206-6. Lancet. 1979. PMID: 85990
-
Impaired prolactin secretion and body fat distribution in obesity.Clin Endocrinol (Oxf). 1990 May;32(5):641-6. doi: 10.1111/j.1365-2265.1990.tb00908.x. Clin Endocrinol (Oxf). 1990. PMID: 2194712
-
Persistence of defective hypothalamic control of prolactin secretion in some obese women after weight reduction.Br Med J. 1980 Aug 2;281(6236):358-9. doi: 10.1136/bmj.281.6236.358-a. Br Med J. 1980. PMID: 6775739 Free PMC article. No abstract available.
-
The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes.Int J Obes Relat Metab Disord. 2000 Jun;24 Suppl 2:S50-5. doi: 10.1038/sj.ijo.0801278. Int J Obes Relat Metab Disord. 2000. PMID: 10997609 Review.
-
Growth hormone in obesity.Int J Obes Relat Metab Disord. 1999 Mar;23(3):260-71. doi: 10.1038/sj.ijo.0800807. Int J Obes Relat Metab Disord. 1999. PMID: 10193871 Review.
Cited by
-
Spontaneous hormonal variations in male cats following gonadectomy.J Feline Med Surg. 2006 Oct;8(5):309-14. doi: 10.1016/j.jfms.2006.03.002. Epub 2006 May 19. J Feline Med Surg. 2006. PMID: 16713320 Free PMC article.
-
Effectiveness of a new approach for exclusive breastfeeding counselling on breastfeeding prevalence, infant growth velocity and postpartum weight loss in overweight or obese women: protocol for a randomized controlled trial.Int Breastfeed J. 2020 Jan 6;15:2. doi: 10.1186/s13006-019-0249-2. eCollection 2020. Int Breastfeed J. 2020. PMID: 31921328 Free PMC article.
-
[Prevention of coronary artery disease].Internist (Berl). 2008 Feb;49(2):154-61. doi: 10.1007/s00108-007-1995-6. Internist (Berl). 2008. PMID: 18214410 Review. German.
-
Obesity as pleiotropic risk state for metabolic and mental health throughout life.Transl Psychiatry. 2023 May 30;13(1):175. doi: 10.1038/s41398-023-02447-w. Transl Psychiatry. 2023. PMID: 37248222 Free PMC article.
-
Dopamine D2 receptor antagonist counteracts hyperglycemia and insulin resistance in diet-induced obese male mice.PLoS One. 2024 Apr 18;19(4):e0301496. doi: 10.1371/journal.pone.0301496. eCollection 2024. PLoS One. 2024. PMID: 38635745 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical